Explore Stanford technologies available for licensing:

Researchers at Stanford University have developed an innovative hardware-based reconfigurable joint limit mechanism and module that precisely constrains a robot's workspace through pre-performance adjustments.

Stanford researchers have developed an innovative mitral annuloplasty ring designed to enhance mitral valve repair surgeries.

Stanford scientists have developed an innovative 3D brain organoid culture system derived from adult neural stem cells to model neurodegenerative diseases like Alzheimer's and enable high-throughput drug screening.

Efficient removal of CO2, a greenhouse gas, from the atmosphere is critical for mitigating climate change and meeting climate goals.

Stanford scientists have developed a gene editing approach that can correct hundreds of hotspot mutations in the COL7A1 gene locus by adapting the Easi-CRISPR strategy with only one set of single guide RNAs (sgRNA).

Systematic reviews of medical research are resource- and labor-intensive, and a cornerstone of the scientific enterprise.

Stanford researchers have designed a safer, lighter, and nimbler robotic arm.

Stanford scientists have developed a wearable neurostimulator device that targets the dorsal genital nerve on the penis to improve and/or expedite male orgasm.

Stanford researchers have developed a strategy for generating chimeric transcription factors that enables exhaustion-resistant CAR-T cells and can be generalized to a wide range of cell therapies.

Stanford scientists have developed a strategy that enables simultaneous and combinatorial genetic screening across different types of genetic perturbations (gene knockouts, knock-ins, overexpression, and gene domain modification).

Stanford researchers have developed a strategy for engineering next-generation cell therapies where gene knock-in is tightly coupled to gene knockout, preventing dangerous side effects associated with cells that have the knockout in the absence of the knock-in and vice versa.

Genetically modified cell therapies, such as CAR-T therapies, have revolutionized cancer treatments.

Stanford scientists have engineered synthetic surface receptors that combine domains from diverse natural receptors to enhance T cell function in challenging immunotherapeutic contexts.

Stanford scientists have developed engineered transcription factors that enhance T cell function and prevent exhaustion by systematically combining functional protein domains.

Stanford researchers have developed a novel approach to selectively regulate and monitor immune responses in specific mucosal tissues, using the GPCR receptor GPR25 and its ligand CXCL17, which targets lymphocyte localization to non-intestinal mucosal tissues, enabling selecti